Thesis
I believe that despite recent positive news regarding Halozyme Therapeutics, such as patent grants and raised financial guidance, the overall bearish sentiment from analysts and a decrease in price targets suggest that HALO may face downward pressure in the near term, making it a strong candidate for a short position.